Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra L Quittner

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Pediatric Pulmonology|July 31, 2010
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisChristopher M Oermann, George Z Retsch-Bogart, Alexandra L Quittner, et al.
Journal of Pediatric Psychology|January 26, 2010
Risk factors associated with depressive symptoms in caregivers of children with type 1 diabetes or cystic fibrosisKimberly A Driscoll, Suzanne Bennett Johnson, David Barker, et al.
Patient Education and Counseling|February 27, 2020
Misunderstandings, misperceptions, and missed opportunities: Perspectives on adherence barriers from people with CF, caregivers, and CF team membersCyd K Eaton, Sara Beachy, Katherine A McLean, et al.
Thorax|October 11, 2015
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxietyAlexandra L Quittner, Janice Abbott, Anna M Georgiopoulos, et al.
Respiratory Medicine|October 9, 2025
Mental health and transplantation in cystic fibrosisAnna M Georgiopoulos, Beth A Smith, Elisabeth P Dellon, et al.
Thorax|October 18, 2014
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scoresAlexandra L Quittner, Anne E O'Donnell, Matthias A Salathe, et al.
Pediatric Pulmonology|February 28, 2014
Tracking CF disease progression with CT and respiratory symptoms in a cohort of children aged 6-19 yearsLeonie A Tepper, Daan Caudri, Elisabeth M W J Utens, et al.
Annals of the American Thoracic Society|March 25, 2015
Adherence Determinants in Cystic Fibrosis: Cluster Analysis of Parental Psychosocial, Religious, and/or Spiritual FactorsDaniel H Grossoehme, Rhonda D Szczesniak, LaCrecia L Britton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 17, 2009
Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapyEdith T Zemanick, J Kirk Harris, Steven Conway, et al.
Pediatric Pulmonology|November 12, 2025
Multidimensional Impacts of Elexacaftor/Tezacaftor/Ivacaftor: Comparisons of Physical and Mental Health Providers' Observations in Cystic Fibrosis in Europe and the United StatesSonia Graziano, Edwina C Landau, Horst Mitmansgrubert, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Pediatric Pulmonology|July 31, 2010
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisChristopher M Oermann, George Z Retsch-Bogart, Alexandra L Quittner, et al.
Journal of Pediatric Psychology|January 26, 2010
Risk factors associated with depressive symptoms in caregivers of children with type 1 diabetes or cystic fibrosisKimberly A Driscoll, Suzanne Bennett Johnson, David Barker, et al.
Patient Education and Counseling|February 27, 2020
Misunderstandings, misperceptions, and missed opportunities: Perspectives on adherence barriers from people with CF, caregivers, and CF team membersCyd K Eaton, Sara Beachy, Katherine A McLean, et al.
Thorax|October 11, 2015
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxietyAlexandra L Quittner, Janice Abbott, Anna M Georgiopoulos, et al.
Respiratory Medicine|October 9, 2025
Mental health and transplantation in cystic fibrosisAnna M Georgiopoulos, Beth A Smith, Elisabeth P Dellon, et al.
Thorax|October 18, 2014
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scoresAlexandra L Quittner, Anne E O'Donnell, Matthias A Salathe, et al.
Pediatric Pulmonology|February 28, 2014
Tracking CF disease progression with CT and respiratory symptoms in a cohort of children aged 6-19 yearsLeonie A Tepper, Daan Caudri, Elisabeth M W J Utens, et al.
Annals of the American Thoracic Society|March 25, 2015
Adherence Determinants in Cystic Fibrosis: Cluster Analysis of Parental Psychosocial, Religious, and/or Spiritual FactorsDaniel H Grossoehme, Rhonda D Szczesniak, LaCrecia L Britton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 17, 2009
Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapyEdith T Zemanick, J Kirk Harris, Steven Conway, et al.
Pediatric Pulmonology|November 12, 2025
Multidimensional Impacts of Elexacaftor/Tezacaftor/Ivacaftor: Comparisons of Physical and Mental Health Providers' Observations in Cystic Fibrosis in Europe and the United StatesSonia Graziano, Edwina C Landau, Horst Mitmansgrubert, et al.
Pageof 17